Cardiff Oncology, Inc. (CRDF)
Total Valuation
CRDF has a market cap or net worth of $256.89 million. The enterprise value is $184.22 million.
Market Cap | 256.89M |
Enterprise Value | 184.22M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRDF has 44.68 million shares outstanding. The number of shares has increased by 2.47% in one year.
Shares Outstanding | 44.68M |
Shares Change (YoY) | +2.47% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 7.56% |
Owned by Institutions (%) | 15.17% |
Float | 41.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 526.42 |
Forward PS | 1,038.58 |
PB Ratio | 3.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 377.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.03.
Current Ratio | 7.42 |
Quick Ratio | 7.19 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.20% and return on invested capital (ROIC) is -63.17%.
Return on Equity (ROE) | -50.20% |
Return on Assets (ROA) | -44.30% |
Return on Capital (ROIC) | -63.17% |
Revenue Per Employee | $15,742 |
Profits Per Employee | -$1.34M |
Employee Count | 31 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +293.84% in the last 52 weeks. The beta is 1.71, so CRDF's price volatility has been higher than the market average.
Beta (1Y) | 1.71 |
52-Week Price Change | +293.84% |
50-Day Moving Average | 2.80 |
200-Day Moving Average | 1.80 |
Relative Strength Index (RSI) | 71.41 |
Average Volume (30 Days) | 1,654,501 |
Short Selling Information
The latest short interest is 2.81 million, so 6.30% of the outstanding shares have been sold short.
Short Interest | 2.81M |
Short Previous Month | 1.15M |
Short % of Shares Out | 6.30% |
Short % of Float | 6.81% |
Short Ratio (days to cover) | 4.23 |
Income Statement
In the last 12 months, CRDF had revenue of $488,000 and -$41.47 million in losses. Loss per share was -$0.93.
Revenue | 488,000 |
Gross Profit | 488,000 |
Operating Income | -45.41M |
Pretax Income | -41.44M |
Net Income | -41.47M |
EBITDA | -41.04M |
EBIT | -41.44M |
Loss Per Share | -$0.93 |
Balance Sheet
The company has $74.82 million in cash and $2.15 million in debt, giving a net cash position of $72.67 million or $1.63 per share.
Cash & Cash Equivalents | 74.82M |
Total Debt | 2.15M |
Net Cash | 72.67M |
Net Cash Per Share | $1.63 |
Equity / Book Value | 69.74M |
Book Value Per Share | 1.56 |
Working Capital | 66.97M |
Cash Flow
In the last 12 months, operating cash flow was -$30.89 million and capital expenditures -$582,000, giving a free cash flow of -$31.47 million.
Operating Cash Flow | -30.89M |
Capital Expenditures | -582,000 |
Free Cash Flow | -31.47M |
FCF Per Share | -$0.70 |
Margins
Gross margin is 100.00%, with operating and profit margins of -9,305.74% and -8,496.93%.
Gross Margin | 100.00% |
Operating Margin | -9,305.74% |
Pretax Margin | -8,492.01% |
Profit Margin | -8,496.93% |
EBITDA Margin | -8,410.45% |
EBIT Margin | -8,492.01% |
FCF Margin | -6,448.57% |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.47% |
Shareholder Yield | -2.47% |
Earnings Yield | -16.14% |
FCF Yield | -12.25% |
Analyst Forecast
The average price target for CRDF is $10.50, which is 93.37% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.50 |
Price Target Difference | 93.37% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 277.13% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
Last Split Date | Feb 20, 2019 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of 6.45 and a Piotroski F-Score of 3.
Altman Z-Score | 6.45 |
Piotroski F-Score | 3 |